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Objective: To assess the technical success and complication rates of the radiologic placement of central venous ports via 
the internal jugular vein.
Materials and Methods: We retrospectively reviewed 1254 central venous ports implanted at our institution between 
August 2002 and October 2009. All procedures were guided by using ultrasound and fluoroscopy. Catheter maintenance 
days, technical success rates, peri-procedural, as well as early and late complication rates were evaluated based on the 
interventional radiologic reports and patient medical records.
Results: A total of 433386 catheter maintenance days (mean, 350 days; range 0-1165 days) were recorded. The technical 
success rate was 99.9% and a total of 61 complications occurred (5%), resulting in a post-procedural complication rate of 
0.129 of 1000 catheter days. Among them, peri-procedural complications within 24 hours occurred in five patients (0.4%). 
There were 56 post-procedural complications including 24 (1.9%, 0.055 of 1000 catheter days) early and 32 (2.6%, 0.074 
of 1000 catheter days) late complications including, infection (0.6%, 0.018 of 10000 catheter days), thrombotic 
malfunction (1.4%, 0.040 of 1000 catheter days), nonthrombotic malfunction (0.9%, 0.025 of 1000 catheter days), venous 
thrombosis (0.5%, 0.014 of 1000 catheter days), as well as wound problems (1.1%, 0.032 of 1000 catheter days). Thirty 
six CVPs (3%) were removed due to complications. Bloodstream infections and venous thrombosis were the two main 
adverse events prolonging hospitalization (mean 13 days and 5 days, respectively).
Conclusion: Radiologic placement of a central venous port via the internal jugular vein is safe and efficient as evidenced by 
its high technical success rate and a very low complication rate.
Index terms: Central venous port; Totally implantable venous access device; Radiologic placement; Internal jugular vein
Received July 25, 2011; accepted after revision November 10, 
2011.
Corresponding author: Hyo-Cheol Kim, MD, Department of 
Radiology, College of Medicine, Seoul National University, 101 
Daehak-ro, Jongno-gu, Seoul 110-744, Korea.
• Tel: (822) 2072-2584 • Fax: (822) 743-6385
• E-mail: angiointervention@gmail.com
This is an Open Access article distributed under the terms of 
the Creative Commons Attribution Non-Commercial License 
(http://creativecommons.org/licenses/by-nc/3.0) which permits 
unrestricted non-commercial use, distribution, and reproduction in 
any medium, provided the original work is properly cited. 
Original Article
Korean J Radiol 2012;13(3):314-323
INTRODUCTION
Since the first report of subcutaneous tunneled central 
venous port (CVP) placement in 1982 (1), a CVP has 
become widely used in the treatment of oncologic patients 
undergoing repeated intravenous chemotherapy. Increasing 
the use of CVPs is attributed to increasing the number 
of forms of chemotherapy, safe and long-term durability 
of CVPs, and satisfying quality of life as well as cosmetic 
results (2-6). 
Currently, the radiologic placement of CVPs has become 
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a widely accepted technique. Several studies have 
demonstrated a high rate of technical success and low rate 
of complication for radiologic placement, compared to 
surgical implantations (7-12). In radiologic placement, the 
internal jugular vein (IJV) is preferred as an access site, as 
it is safely accessed under ultrasound (US) guidance and 
located away from the lung or nerve plexus, and results in a 
low procedural complication rate (10, 11, 13-15). 
We began the radiologic placement of CVPs in 2002, 
and have implanted 1254 CVPs via the IJV in oncologic 
patients. In this long-term retrospective study, we report 
a single center experience on a large number of radiologic 
placements of CVPs exclusively via the IJV, with respect to 
technical success, complication rates, and clinical outcome.
MATERIALS AND METHODS 
Study Populations 
Between August 2002 and October 2009, 1254 CVPs in 
1237 adult patients with an average age of 57 ± 12 years 
(range 18-84 years) were implanted by an interventional 
radiology team at our institute. In all patients, CVP 
placement was indicated for the administration of 
chemotherapy. We used three kinds of port systems; Celsite 
(9.6 Fr, B. Braun Medical, Boulogne, France), Vortex (8 Fr, 
AngioDynamics, Latham, NY, USA), and Healthport (8 Fr, 
Baxter S.A., Fromet) (Table 1). Exclusion criteria were as 
follows: active systemic infection, local infection at the 
port implantation site, uncorrectable coagulopathy with 
a platelet count < 50/nl, PTT < 50% and INR > 1.5, and 
acute venous thrombosis or chronic complete obstruction 
at the IJV or the superior vena cava. Demographic data 
and underlying diseases are shown in Table 1. Institutional 
Review Board approval was obtained for this study.
Procedure 
Written informed consent was obtained from each 
patient before conducting the procedure. The procedure 
was performed in an interventional radiology suite by 
12 interventional radiologists and rotating residents of 
radiology. It has been our internal policy that residents, 
after a month of observation, carried out the first 10 
implantations under supervision of an experienced 
interventional radiologist.
Antibiotic prophylaxis was used in high risk patients 
according to clinicians’ decision according to a patient’s 
disease status or absolute neutrophil count. For the 
patients with absolute neutropenia (white blood cell count 
< 500/mm
3), 1 gram of cefazolin sodium was intravenously 
administrated before the procedure. None of the procedures 
employed sedation or was attended by an anesthesiologist.
US examination of the IJV was performed prior to skin 
preparation in order to screen the patency and the size 
of the vein, and to rule out venous thrombosis. The right 
IJV was preferentially selected for the initial access route. 
However, the left side was chosen in 57 patients due to 
postmastectomy status, postradiation therapy status, 
venous thrombosis on surveillance US, or the presence of a 
previously inserted catheter on the right side.
During the entire procedure, special caution was paid 
to the maintenance of maximum sterile conditions. After 
local anesthesia with 1% lidocaine, a selected vessel 
was punctured under real-time US-guidance using a 21-G 
needle. After successful puncture, an 0.018-inch wire, 
followed by a 5 French dilator, was inserted along the 
wire. The port reservoir pocket was created, and we packed 
povidone iodine balls within the pocket for hemostasis and 
disinfection. Then, an 0.035-inch guidewire was advanced 
through a 5 French dilator to the superior vena cava 
and further into the inferior vena cava to assure venous 
puncture. The puncture tract was serially dilated and an 
8.5 or 10 French peel-away sheath was inserted into the 
IJV. The port catheter was tunneled from the pocket to the 
puncture site and introduced into the superior vena cava 
through the peel-away sheath. The catheter tip was placed 
at the level of the cavoatrial junction or 2-3 cm below the 
carina, and was confirmed by fluoroscopy. In the case where 
a cavoatrial junction was not conclusive on fluoroscopy, 
we preferred to place the tip lower rather than higher in 
relation to the suspected cavoatrial area (16). The patency 
of the port system was checked by aspirating blood and 
injecting normal saline without any problem. The skin 
incision was sutured using nylon 3-0. Suture of the port to 
the pectoralis fascia was not performed in all implantations. 
Finally, a fluoroscopic image in the supine position and a 
chest radiograph in the upright position were obtained to 
observe the position of the catheter tip and the presence of 
complications such as pneumothorax. 
Management of a CVP 
The CVP was used from the day of implantation or the 
next. A 21- or 22-G Huber needle was used for infusion of 
the chemotherapy agent. Before use, a patient’s skin was 
disinfected with povidone iodine and the CVP was tested Korean J Radiol 13(3), May/Jun 2012 kjronline.org 316
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by aspirating blood and infusing normal saline. After use, 
normal saline was flushed to fill the port and the catheter. 
In the condition that the port was not used for more than a 
month, a diluted heparin solution was flushed every month.
Follow Up 
We retrospectively reviewed fluoroscopic images, chest 
radiographs, and medical records. The deadline of data 
collection was July 31, 2010. A total of 376 ports reached 
Table 1. Summary of Study Population
Number %
Age 57 ± 12*
Sex Male 693 56
Female 544 44
Underlying disease  Colorectal cancer 728 58.9
Stomach cancer 232 18.8
Other gastrointestinal tumor 13 1.1
Hepatobiliary cancer 27 2.2
Pancreatic cancer 11 0.9
Gynecological malignancy 30 2.4
Genitourinary system malignancy 7 0.6
Breast cancer 93 7.5
Skeletal tumor 23 1.9
Lung cancer  14 1.1
Brain tumor 4 0.3
Other solid tumors 2 0.2
Hematologic malignancy 53 4.3
Puncture site Right internal jugular vein 1197 95.5
Left internal jugular vein 57 4.5
Port Celsite
† 907 72.3
Vortex VX
‡ 232 18.5
HealthPort
§ 115 9.2
Catheter maintenance days Total days 433386
Mean days 350 ± 237*
Note.— *Average ± standard deviation, 
†B. Braun Medical, Boulogne, France, 
‡AngioDynamics, Latham, NY, USA, 
§Baxter S.A., 
Fromet
Maintenance of port till time 
of review in July 2010 
(n = 376)
Loss of follow-up
(n = 403)
Expire during follow-up
(n = 127)
Catheter maintenance days: 433386 days
Central venous port implantation 
between August 2002 and October 2009 
(n = 1254 ports in 1237 patients)
Removal (n = 348)
i)  Completion of chemotherapy or no
  further treatment (n = 307)
ii) Patient’s demand (n = 5)
iii) Complication (n = 36)
Fig. 1. Study population and follow-up flow chart.Korean J Radiol 13(3), May/Jun 2012 kjronline.org 317
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the deadline. The remaining ports did not reach the 
deadline due to being lost to follow-up (n = 403), death 
(n = 127) or removal of CVPs (n = 348) (Fig. 1). The last 
date of follow-up was defined as the date of the latest visit 
to the hospital, death date by a death registry on medical 
records, or the date of CVP removal. Catheter maintenance 
days were calculated as the number of days between 
implantation and the last date of follow-up.
Definition 
Complications were classified into three groups based 
on the timing of onset; periprocedural (< 24 hours), early 
(≤ 30 days), or late (> 30 days), which were classified 
according to the Society of the Interventional Radiology 
(SIR) Technology guidelines (17). 
Catheter dysfunctions encompass any conditions where 
a CVP is unusable for infusion. These conditions include 
thrombotic causes (occlusion at the catheter tip or lumen, 
fibrin-sheath formation, or chamber thrombosis) as well 
as nonthrombotic causes (catheter migration, kinking of a 
catheter, or port rotation), which are confirmed by typical 
imaging findings on fluoroscopic port function check or 
chest radiographs. 
Catheter-related infections are divided into local 
infections (pocket infection, tunnel infection, or wound 
infection) and blood stream infections (bacteremia or 
sepsis). Local infections usually present with erythema, 
tenderness and/or induration near the pocket or along the 
tunnel, or are sometimes associated with the presence 
of pus (5). Catheter-related blood stream infections are 
defined when a blood culture is positive without other 
identifiable sources of infection, and clinical signs resolve 
within 48 hours after port explantation (6). Among them, 
catheter-related sepsis is specifically defined when clinical 
signs are compatible with sepsis, which is a systemic 
inflammatory response syndrome (17). 
Complications were graded by its outcome as minor 
(Group A or B) or major (Group C, D, E, or F) according to 
SIR classification. Complications requiring hospitalization 
more than overnight admission were considered as major 
complications, and major complications were subdivided 
into four groups as follows: hospitalization less than 48 
hours (Group C), prolonged hospitalization of more than 48 
hours (Group D), permanent adverse sequelae (Group E) and 
death (Group F) (17). 
RESULTS
A total of 1254 CVPs were implanted in 1237 patients. A 
total of 433386 catheter maintenance days were recorded,, 
and the mean catheter indwelling time was 350 ± 237 days 
(range, 1-1165 days). Catheterization was performed via the 
right IJV in 95.5% of patients, and the left IJV in 4.5% of 
patients. 
During follow-up period, 348 CVPs (27.8%) were 
explanted. Among these, 307 (24.5%) were removed after 
completion of chemotherapy or in patients with no further 
treatment plan, 36 CVPs (2.9%) had to be removed due 
to complications, and five (0.4%) were explanted upon 
patients’ demands (Fig. 1). 
Technical success was achieved in 1253 implantations 
(technical success rate, 99.9%). In one patient, the 
right carotid artery was accidentally punctured during 
a trial of right IJV puncture with a 21-G needle. After 
needle removal and manual compression, US examination 
revealed hematoma. We observed five periprocedural 
complications (0.40%), including the one case of arterial 
puncture mentioned above. Hematomas developed in three 
implantations (0.24%), and were initially managed by 
manual compression and compressive dressings. However, 
two of them finally had to be explanted because of constant 
oozing hemorrhage from the pocket and patient discomfort. 
One patient (0.08%) experienced cardiac arrhythmia during 
and after the procedure, which was resolved spontaneously 
(Table 2). 
In total, 56 post-procedural complications (4.47%, 
Table 2. Periprocedural Complications
Type of Complication No. of Patients  %
Management 
Correction*  Removal
Hematoma at pocket site 3  0.24 1 (compressive dressing)  2
Cardiac arrhythmia 1  0.08 1 (spontaneous resolution) 0
Arterial injury 1 0.08 1 (manual compression)  0
Total 5 0.40 3 2
Note.— *Management details are described in parentheses.Korean J Radiol 13(3), May/Jun 2012 kjronline.org 318
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0.129/1000 catheter days) occurred over 433386 catheter 
maintenance days. There were 24 (1.90%, 0.055/1000 
catheter days) early and 32 (2.55%, 0.074/1000 catheter 
days) late complications, which are summarized in Table 
3. Late complications developed as late as 418 days after 
implantation and were attributed to thrombotic catheter 
occlusion. 
A total of 8 infectious complications (0.64%, 0.018/1000 
catheter days) occurred. Four infections were early 
complications, and four were late complications as follows: 
A
D
B
E
C
Fig. 2. Case of catheter migration. 
A. We placed central venous port via right internal jugular vein in 68 year-old woman with its tip just below carina at T5 level. B. Chest 
radiograph in erect position showed that catheter is retracted and tip is located somewhere in brachiocephalic or internal jugular vein. Patient 
is obese with pendulous breasts. C. On fluoroscopy in supine position, catheter tip is further migrated cephalad into right internal jugular vein. 
Patient complained of neck pain on infusion. D. After removal of port, another port was implanted via left internal jugular vein, and tip was 
placed deeper in upper portion of right atrium. E. Chest radiograph in erect position revealed that catheter was once again retracted with its tip 
probably located in left brachiocephalic vein.Korean J Radiol 13(3), May/Jun 2012 kjronline.org 320
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catheter-related sepsis (n = 1), febrile catheter-related 
bacteremia (n = 6), and port pocket infection (n = 1). Ports 
were immediately explanted in all infectious complications, 
except for one patient of transient febrile bacteremia which 
was treated with systemic antibiotics. 
Catheter dysfunctions occurred in 28 patients (2.24%, 
0.065/1000 catheter days); 17 thrombotic (1.36%, 
0.040/1000 catheter days) and 11 nonthrombotic (0.88%, 
0.025/1000 catheter days) dysfunctions. Thrombotic 
malfunction tended to develop late, whereas most of 
nonthrombotic malfunctions were early complications. Of 
17 thrombotic dysfunctions including catheter occlusion 
(n = 5), fibrin sheath formation (n = 9), and chamber 
thrombosis (n = 3), 10 CVPs had to be explanted. Others 
were successfully corrected by flushing normal saline (n = 
2), thrombolysis using urokinase (n = 2) or endovascular 
stripping (n = 3). Nonthrombotic dysfunctions included 
catheter migration (n = 4) (Fig. 2), kinking of the catheter 
(n = 3), and port rotation (n = 4), which were treated by 
repositioning (n = 7) or removing (n = 4) in the case of 
failure of reposition. 
We had two Group C complications and 11 Group 
D complications, which resulted in prolongation of 
hospitalization (range, 2-31 days). Of the 13 major 
complications, seven were blood steam infections 
(mean prolongation of hospitalization, 13.3 days), 
while six were venous thrombosis (mean prolongation of 
hospitalization, 6.3 days). These required hospitalization 
for the administration of intravenous antibiotics and 
anticoagulants, respectively. There were no serious 
complications resulting in permanent adverse sequelae or 
death.
DISCUSSION
As a reliable and stable central venous access, a CVP 
has been widely adopted since the 1980s and has become 
increasingly popular, especially for the care of oncologic 
patients (11, 18). Several studies have reported CVPs to 
be more durable and to have a longer patency in terms of 
lower infectious complication and malfunction rates than 
tunneled or peripheral catheters (9, 19). In many studies, 
mean catheter maintenance time was over 10 months (3, 4, 
16), which was also shown in our study. Moreover, Gebauer 
et al. (5) reported a high level of patient satisfaction with 
CVPs. In spite of the palpable and visible port chamber in 
the chest wall, it does not limit a patients’ daily life and 
allows for a high quality of life in the patients undergoing 
long-term intravenous chemotherapy. 
Several studies reported that radiologic placement of 
a CVP is superior to anatomical landmark-guided surgical 
insertion in terms of technical success, time required for 
puncture, and complications. The complication rates of the 
cut-down technique were conducted via the cephalic vein 
range 16-21% (6, 20, 21). Various complication rates have 
been reported for surgically implanted CVPs ranging from 
5.0-24.6% (6) (4, 7, 8). In the radiologic placement of a 
CVP, the procedure was performed under the guidance of 
US and fluoroscopy and using the Seldinger technique (6, 
15). US-guidance enables the evaluation of the patency 
and the size of vessels, clear visualization of a vessel to 
guide puncture and, therefore, a high technical success rate 
of nearly 100% (4, 11, 13, 15, 22). Fluoroscopy-guidance 
enables the visualization of the location of a catheter 
tip, and the course of a catheter, as well as immediate 
evaluation of port function. We preferred the IJV for the 
initial access site than the subclavian vein (SCV). The 
IJV is considered superior to the SCV technical success, 
complication rate, and procedure time. Overall technical 
difficulty and complications reported for SCV access range 
from 10-20% and 1-30%, respectively (4, 23-25). Even 
though radiologic guidance may help localization of the 
SCV and decrease the arterial puncture or pneumothorax, 
technical difficulties including catheter handling to 
advance a catheter into the brachiocephalic vein and , in 
consequence, mal-positioning of a catheter remain due 
to an acute angle when the SCV joins the IJV to form 
the brachiocephalic vein (24). In addition, the IJV has 
a straight course to the superior vena cava, allowing for 
less contact of the catheter with the vessel wall and thus 
a lower risk of venous thrombosis (23). Moreover, some 
complications such as pneumothorax or pinch-off syndrome 
occur only in SCV access (4, 5, 13, 26).
Total complication rates of radiologic placement of CVPs 
have reported from 4.4 to 14% in the studies of various 
population sizes and access routes (3-6, 14, 15, 27, 28). 
The largest series of 8156 port placements by Moureau 
et al. (14) reported total complication rate of 0.52 per 
1000 catheter days. The latest large study by Teichgräber 
et al. (6) reported total complication rate of 11.8% in 
3160 CVP implantations, and 0.41 complications per 1000 
catheter days in 2622 CVP implantations. Our results were 
comparable to the previous studies when calculating the 
complication rate by a percentage of total implantations Korean J Radiol 13(3), May/Jun 2012 kjronline.org 321
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(4.85%), whereas we achieved relatively lower complication 
rate when calculating it based on the total catheter 
maintenance days (0.129 per 1000 catheter days) due to 
relatively longer catheter maintenance days.
Infectious complications are of clinical importance 
because they are a major cause of hospitalization 
prolongation, as shown in our study. Various infectious 
complication rates have been reported in the literature 
ranging from 1.1 to 8.8%, or from 0.10 to 0.27 per 1000 
catheter days (3-6, 13, 14, 29). Moureau et al. (14) reported 
an infectious complication rate of 0.30 per 1000 catheter 
days in 8156 CVP implantations. In a systemic review of 18 
previous studies including 3007 ports by Maki et al. (30), a 
blood-stream infection rate of 0.10 per 1000 catheter days 
was reported. Compared to previous studies, we achieved 
a lower infectious complication rate (0.64%, 0.018 per 
1000 catheter days). We attribute our lower infection rate 
to our standardized protocol, where we strictly applied 
aseptic techniques during implantation as well as before or 
after each use, and we used povidone iodine balls to clear 
bleeding and eliminate possible causes of infection within 
the pocket. For now, the benefit of prophylactic antibiotics 
is controversial (5, 31). In a few studies on risk factor 
analysis for infectious complications (29, 31), it has been 
shown that hematogeneous malignancy is better associated 
with infections than solid malignancies. Therefore, further 
analysis is warranted considering that a variety of patient 
factors including age, immune status, underlying disease as 
well as technical factors such as access site and operators’ 
experience, also might affect the results. 
Regarding catheter dysfunction, thrombotic dysfunctions 
have been reported to be relatively common (3, 5, 6) 
and have a tendency to occur later than nonthrombotic 
dysfunction, as also shown in our study. According to the 
systemic review of 57 articles by Groossens et al. (32), 
about one-third of previous articles reported catheter 
malfunction rates less than 1%. However, higher incidences 
of 9.2% (33) or even 47% (34) were also reported. The 
differences are considered to arise from the various ways 
of defining dysfunctions and calculating dysfunction 
rates. Therefore, Goossens et al. (32) suggested that 
a well-functioning CVP should be clearly defined, and 
dysfunction rates should be calculated as a percentage of 
access attempts to represent more functionality. However, 
retrospective data acquisition of the number of access 
attempts seems to be practically neither easy nor reliable. 
In managing thrombotic dysfunctions by fibrin sheath 
formation, we performed endovascular stripping successfully 
in one-third of cases. However, Heye et al. (35) reported a 
higher success rate of 91.9% for the endovascular stripping 
technique when additional techniques to mobilize the distal 
catheter tip from the vessel wall with a snare catheter were 
applied. 
All dysfunctions due to catheter migration early 
complications. They were frequently detected on erect 
chest radiographs in obese women or those with pendulous 
breasts, as shown in our case (Fig. 2). According to Schutz 
et al., catheter tips migrated cephalad at an average of 
20 mm in the erect position, and tip positioning deep 
into upper portion of the right atrium decreased the 
risk of catheter malfunction (16). In addition, catheter 
malposition increases the risk of venous thrombosis (36), 
or causes kinking of a retracted cathter (37). Therefore, 
the placement of the catheter tip deeper into the right 
atrium in obese patients or those with pendulous breasts 
is recommended. Rotation of the port is not a frequently 
reported complication, but we had four cases (0.32%, 
0.009 per 1000 catheter days), for which we did not fix 
with suture. The port base had been fixed to the pectoralis 
major with suture or glue (18). However, several studies 
have reported that if the pocket is tight enough, a fixation 
suture is not necessary (18, 38). If a pocket is created too 
large or subcutaneous fat tissue is loose, a fixation suture 
may be helpful to prevent rotation of the port (3). 
Our study showed the venous thrombosis to be the second 
most important complication in terms of prolongation of 
hospitalization for the use of intravenous anticoagulants 
(mean hospitalization prolongation: 4.8 days). It has been 
documented to occur with an incidence of 0.3-11.7% (4, 
6, 20, 36) or 0.04-0.105 per 1000 catheter days (5, 6), 
depending on catheter tip location, catheter insertion 
site, or indwelling duration (16, 20, 36). We had 6 venous 
thromboses in the IJV, the superior vena cava, and the 
right atrium and two of them were associated with catheter 
malposition. In addition, IJV and right catheterization 
is associated with a lower risk of venous thrombosis 
compared to SCV and left catheterization because of the 
straight course of a catheter and minimized vascular 
injury by catheter movement (36). However, catheter-
related thrombosis did not differ between radiologic 
placement or the surgical cutdown technique (20), and 
thromboprophylaxis has no significant effect on the 
reduction of venous thrombosis (20, 39). 
The limitation of our study is, first of all, its retrospective Korean J Radiol 13(3), May/Jun 2012 kjronline.org 322
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nature. We did not make a statement on complication 
rates in association with access site, a type of port, or 
the use of prophylactic antibiotics, because of intrinsic 
difficulties to control the various relevant factors such as 
patient primary disease, immune status, age, the number 
of port usage, port management, and so on. Second, we 
didn’t evaluate subjective symptoms such as pain, vomiting 
or dizziness because there were no reliable, standardized 
criteria to score them and clarify the relationship with port 
implantation. Third, there is a possibility of missing a few 
complications which were neither stated in medical records 
nor referred to our intervention team, and immediately 
managed by clinicians; for instance, tip occlusion which was 
resolved simply by flushing saline as well as a small amount 
of hematoma or minor wound dehiscence. This might have 
resulted in a decrease in the total complication rate, but 
these complications are not of much clinical importance in 
terms of outcome or cost.
Our study is a retrospective study of radiologic placement 
of CVPs, including a large number of study populations at a 
single institute. This large retrospective study demonstrated 
that US and fluoroscopy-guided CVP placement, especially 
via the IJV, is safe and effective with an extremely high 
technical success rate, low peri- and post-procedural 
complication rates, and satisfactory clinical outcome. 
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